4.5 Article

Value-Based Insurance Design: Quality Improvement But No Cost Savings

Journal

HEALTH AFFAIRS
Volume 32, Issue 7, Pages 1251-1257

Publisher

PROJECT HOPE
DOI: 10.1377/hlthaff.2012.0902

Keywords

-

Funding

  1. Aetna Inc.
  2. Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization Initiative [67461]
  3. Blue Cross Blue Shield of North Carolina
  4. Research Career Scientist Award from the Department of Veterans Affairs [RCS 10-391]
  5. Daichi Sankyo
  6. Takeda Pharmaceuticals
  7. Novartis
  8. ResDAC at the University of Minnesota
  9. Surgical Review Corporation

Ask authors/readers for more resources

Value-based insurance design (VBID) is an approach that attempts to improve the quality of care by selectively encouraging or discouraging the use of specific health care services, based on their potential benefit to patients' health, relative to their cost. Lowering beneficiary cost sharing or out-of-pocket spending to increase medication adherence is one common element of value-based insurance design. We conducted a systematic review of the peer-reviewed literature to evaluate the evidence of the effects of VBID policies on medication adherence and medical expenditures. We identified thirteen studies assessing the effects of VBID programs and found that the programs were consistently associated with improved adherence (average change of 3.0 percent over one year), as well as with lower out-of-pocket spending for drugs. In the studies we reviewed, providing more generous coverage did not lead to significant changes in overall medical spending for patients and insurers. Further research is needed to understand how best to structure VBID programs to both improve quality and reduce spending.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available